Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics Revenue

Soleno Therapeutics had revenue of $94.60M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $285.01M. In the year 2025, Soleno Therapeutics had annual revenue of $190.41M.

• Revenue (ttm): $285.01M
• Revenue Growth: n/a
• P/S Ratio: 9.69
• Revenue / Employee: $1,565,978
• Employees: 182
• Market Cap: 2.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	190.41M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error